“Molecule 520” Changes Everything
The last time we saw a breakthrough like this, investors made up to 70,000% gains (but they had to get in early)…
Dear Reader,
George Johnson, 46, has been an alcoholic all his life.
Most of us know someone like George.
His drinking destroyed his career, broke up his family, and almost killed him.
He missed his daughter’s high school graduation because he was passed out from drinking.
He tried everything to quit — and several times he did stop drinking, but not for long.
And even when he wasn’t drinking, he lived in constant fear of slipping and taking a drink.
Life was a constant struggle to stay sober.
Then George heard about a clinical trial being run at an Ivy League university that changed his life.
The researchers said they were studying a breakthrough treatment that wasn’t just about “managing” alcoholism but eliminating it.
A treatment that could turn an alcoholic into a nonalcoholic.
One minute, the person craves alcohol. The next minute, he no longer drinks.
Naturally, George was skeptical, but he figured he had nothing to lose.
And after just two sessions with this breakthrough treatment…
He’d lost all desire to drink alcohol.
Any fear of falling off the wagon was gone.
In short, George was an alcoholic before the treatment. Now he’s not.
This is a true story based on a rigorous scientific study conducted at one of the most prestigious and respected medical laboratories in the world.
And George Johnson’s story is not unique but one of many like it.
You see, this groundbreaking treatment is being used as we speak to treat not just alcoholism but many incurable chronic diseases.
And it can not only turn an alcoholic into a nonalcoholic, but it can also turn a depressed person into someone who isn’t depressed.
Or turn an opioid addict into a nonaddict.
It can help give a diabetic a normal blood sugar level.
“This is going to save millions of lives. Why wouldn’t I want to be invested?”
— Kevin O’Leary, Shark Tank
Or even enable an Alzheimer’s patient to remember again.
I know it sounds incredible. But this is not some far-off fantasy…
This treatment actually exists… right now.
And it’s already transforming people’s lives.
A Massive Breakthrough
This treatment is based on what’s being called the “Molecule 520,” and it is revolutionizing medicine as we know it.
For example, the establishment doesn’t believe alcoholism can be cured.
Once an alcoholic, always an alcoholic, it says.
But the standard ways of treating alcoholism just don’t work very well.
Between 40%–60% of people who’ve been treated for addiction or alcoholism relapse within a year, according to The Journal of the American Medical Association.
And alcoholism must be managed for life.
That’s why this new treatment is so revolutionary: It doesn’t manage alcoholism… It eliminates it.
With as little as one treatment!
And study after study is proving it works on many other chronic diseases, too.
Studies underway at places like Harvard, Johns Hopkins, and Stanford are showing this new treatment is effective against other deadly chronic diseases that affect millions…
Like depression, diabetes, PTSD, opioid addiction, anorexia, and Alzheimer’s disease.
This Molecule 520 Is Changing People’s Lives
Practically Overnight
Take Elise Farmer, a 55-year-old woman who’d been severely depressed for decades.
On a good day, she was able to get out of bed and make a meal for herself.
But most days, she stayed in bed alone with the curtains drawn and had her food delivered.
More than once, she thought about ending her life.
Then a friend told her about a clinical trial for a brand-new treatment for depression that needed volunteers.
Like George, Elise had tried everything to cure her depression: expensive, long-term therapy and antidepressants with lots of terrible side effects.
Nothing worked very well or for very long. And that’s common.
Antidepressants coupled with expensive, long-term therapy work only about 40%–60% of the time.
So naturally, she was skeptical about this new “cure,” too.
But after one session… her depression lifted.
And in the following days, she reported feeling better and better every day.
Now, for the first time in decades, Elise feels good. She’s healthy, happy, and excited about life.
Bottom line…
Elise was deeply depressed. Now her depression has disappeared. Completely.
Both Elise and George got virtually identical outcomes…
Complete relief with lasting results after only one or two treatments using this Molecule 520.
And they aren’t the only ones.
Studies involving tens of thousands of people with incurable chronic diseases have used this same new treatment to deliver similar results.
The FDA Opens the Floodgates
by Awarding “Breakthrough Status”
Because the Molecule 520 has shown incredible promise to transform millions of people’s lives for the better…
It’s got the Food and Drug Administration’s backing.
The FDA — the ultimate judge of safety and effectiveness for medical treatments — has awarded this new medicine “breakthrough status.”
The FDA only assigns breakthrough status to treatments in which clinical evidence “demonstrates the drug [or therapy] may have substantial improvement on at least one clinically significant endpoint over available therapy.”
In short, breakthrough status means cutting red tape for fast commercial development and getting to market in a fraction of the time it normally takes.
And this FDA backing has thrown the floodgates wide open.
“A growing number of companies are conducting clinical trials of [this same cure] for everything from depression to post-traumatic stress disorder with the blessing of the FDA.” — Bloomberg
Both Big Pharma and tiny startups are spending billions on research and development, with several drugs already in Stage 2 trials…
Big money is pouring in from venture capitalists and Silicon Valley titans…
And the first wave of IPOs is about to hit the market…
Offering anyone who gets on board now the chance for our next round of triple- and quadruple-digit profits.
If fact, some say the little-known company that just filed for its IPO could be the next “unicorn”… a startup worth $1 billion.
Why Haven’t You Heard About This Until Now?
If you’re like 99% of investors, this is probably the first time you’ve heard of the Molecule 520.
Few people are familiar with it — even among medical professionals.
But not for long. Because the Molecule 520 is throwing out the standard playbook for treating many chronic diseases.
It’s a revolutionary new development curing diseases that have long been thought to be incurable.
Remarkably, this Molecule 520 is 100% natural, organic, and plant-based, so it’s free of the negative side effects that plague people with most medications for these diseases.
(Now, I know what you might be thinking, but let me be clear upfront that I’m NOT talking about cannabis.)
And best yet, this breakthrough treatment involves:
No synthetic drugs with side effects.
No invasive surgery.
No long, expensive therapy of any kind.
No restrictions on your lifestyle.
No outrageous costs.
It literally makes the disease disappear, leaving the patient whole and healthy, often for the first time in years.
Addicts become nonaddicts.
Depressed people no longer have depression.
And PTSD sufferers no longer have PTSD.
This breakthrough treatment simply “removes” the disease.
Sound too good to be true?
I thought so at first, too. But this Molecule 520 is the real deal…
I’ve read thousands of pages of research, and studies around the world are showing equally promising results for people suffering from autoimmune diseases, epilepsy, chronic Lyme disease, Alzheimer’s disease, and many others.
One prominent scientist has called this new breakthrough:
“The most important discovery in half a century.”
— Science Magazine
What is this Molecule 520 exactly?
And how does it work?
In the next few minutes, I’ll give you the answers…
And show you why the world’s most successful investors — like Peter Thiel and Kevin O’Leary — are pouring tens of millions into this.
Best yet, I’ll show you how you can follow them and get in on the ground floor of a medical breakthrough that will change medicine as we know it…
And make early investors very rich.
Three Decades of Triple-Digit Gains
Hi, I’m Jeff Siegel and I’ve been a professional investor for 30 years.
I’m also a bestselling author, television commentator, and editor of the highly successful investment publication Green Chip Stocks.
And my specialty is investing in “world-changing breakthroughs” long before they become household words…
Giving my readers opportunities to make a fortune before most investors even know what’s happening.
Uncovering game-changing advances before the crowd catches on is my secret for helping others make life-changing amounts of money.
I spend a lot of time on the road visiting companies, doing site visits, and talking directly to management.
That’s how I became one of the first to call the boom in alternative energy, which helped make my readers millions of dollars.
Like when I recommended SunPower Corporation (NASDAQ: SPWR) — before it shot up FIVE TIMES its value…
That turned every $5,000 into $24,800!
And when I told my readers to buy First Solar (NASDAQ: FSLR), they made out like bandits when it exploded with an 850% gain…
That turned every $5,000 into $47,500!
But we were just getting warmed up.
I told folks to get into Vestas Wind Systems (OTCMKTS: VWDRY) at $75 a share — and after that, it went parabolic…
All the way up to $666 a share!
Five thousand dollars in that stock would have turned into $44,400!
I was also one of the first to see the cannabis revolution coming before it was on most investors’ radars.
By getting on board early, I showed readers how to rack up incredible gains like:
3,016% on Canopy Growth Corporations.
1,185% on OrganiGram Holdings Inc.
1,174% on Aphria Inc.
A small $5,000 grubstake in each of these cannabis stocks would have turned your investment into a whopping $268,750.
A $10,000 investment in each of these stocks would have given you a $537,500 windfall.
And $20,000 in each… Well, that would have delivered a life-changing $1,075,000 fortune.
As you can see, we have a killer record of triple- and quadruple-digit gains.
And we do it over and over again.
That’s why it’s so important you keep watching this presentation.
Because today, I see the chance to do it again with this Molecule 520.
The companies I am going to tell you about could dwarf those previous winners and create our next round of millionaires.
And I’m not the only one who sees the enormous potential here…
The Big-Money Players Are
Racing to Claim Their Share Now
Kevin O’Leary of Shark Tank fame has invested $6 million (and counting) into the Molecule 520.
PayPal co-founder and legendary venture capitalist Peter Thiel is in, too.
He turned an early $500,000 investment in Facebook into $1 billion and was an early investor in LinkedIn, SpaceX, and Airbnb to name a few of his other big winners.
Now he is backing a company in this space with an undisclosed amount, though it’s common knowledge he never “goes small when he can go big.”
So is Bruce Linton, founder of Canopy Growth. Bruce made 70,000% on cannabis when his company’s stock price went from $0.10 to $70 a share.
He’s betting big money this Molecule 520 will be much, much bigger than cannabis.
Ultimately by as much as 10–20 times bigger.
In fact, a lot of elite cannabis investors are pouring money into this new opportunity.
They see this as a repeat of what happened in the early days of cannabis stocks…
The chance for a massive payoff for folks who get in early.
Expect Four-Figure Gains From This Game-Changer
Big Pharma and biotech companies are pouring hundreds of billions of dollars into developing drugs based on the Molecule 520.
Pharmaceutical giant Johnson & Johnson already has one Molecule 520-based treatment approved and on the market. It’s a nasal spray aimed at helping people who suffer from depression.
The FDA has already fast-tracked two other drugs in development.
There are dozens of drugs already in clinical trials, and some are in the final Stage 3 trials, which are the last step before applying for FDA approval.
And all the companies and startups I’ve talked to are working with the FDA to get their efforts fast-tracked, too.
That’s why you must make your move now…
Because biotech companies on the cusp of new discoveries can go parabolic.
Look what happened to Medivation (NASDAQ: MDVN) when it announced a new treatment for prostate cancer.
Questcor Pharmaceuticals (NASDAQ: QCOR) developed a drug that relieves the symptoms of MS and its stock went through the roof.
And when Illumina (NASDAQ: ILMN) made strides with gene editing, it made early investors rich.
A one-time $500 investment in MDVN turned into over $55,000.
And the Molecule 520 stocks I’m recommending today could absolutely match those stellar gains.
Here’s Why Legendary Investors Are Going All In…
This breakthrough could be the single most efficient way to treat the most stubborn and costly diseases plaguing society.
Right now, scientists around the world are studying the Molecule 520’s impact on chronic diseases that afflict millions, including:
Just look at the money now spent to treat these diseases every year:
$635 billion on chronic pain.
$78 billion on PTSD.
$150 billion on depression.
$39 billion on smoking cessation.
$35 billion on treatment for alcoholism.
When you include the other diseases this Molecule 520 can treat, there’s more than $1.7 TRILLION being spent.
If this new breakthrough captures just 1% of this market (and I think it will capture far more than that), we’re looking at billions in profits.
That’s why the world’s biggest investors are going all in… NOW. Before this hits the mainstream financial media.
As Kevin O’Leary put it, “This could save lives, cure depression, help alcoholism, get people off opioids — why wouldn’t I want to be invested?”
He’s making his move now because heavyweight investors know…
This Is the Next Big Thing in Medicine
To grasp the tremendous size of this opportunity, think about game-changing medical breakthroughs like penicillin, vaccines, anesthesia, and antibiotics.
Those major advances transformed our world… saved many hundreds of millions of lives… and eliminated untold suffering.
Scientists estimate vaccines alone have prevented 103 million cases of deadly and crippling childhood polio, smallpox, measles, flu, and others.
And before antibiotics, an infection was often a death sentence. Nothing could stop it.
Experts say penicillin alone saved 80 million–200 million lives… and counting!
And that’s not even counting all the lives other antibiotics have saved.
Now, this one breakthrough could do the same for the:
1 billion people who smoke.
264 million people who suffer from depression.
35 million who suffer from PTSD.
38 million who suffer from alcoholism.
15 million who suffer from opioid addiction.
44 million who suffer from Alzheimer’s disease.
30 million who suffer from anorexia.
And 70 million who suffer from arthritis.
It’s Already Saving the Lives of Our Soldiers
Post-traumatic stress disorder, known as PTSD, affects 12% of our veterans.
The impact on a soldier and his family is horrific.
And the pain and shame can lead to a “wounded warrior” taking his own life.
Long-term therapy and antidepressive medications are the usual treatments for PTSD.
But when military veteran and PTSD sufferer Bill Higgins tried this new breakthrough cure, here’s what he reported:
When I returned from Iraq working in IED demolition and combat, the war had changed me. The VA was ill-equipped to help me transition and deal with my PTSD.
I was heavily medicated. This [new medicine] saved me. My life was renewed. I now have peace and purpose, and I can’t wait to share this opportunity with the world.
And study after study from the most prestigious universities and institutions around the world like:
Harvard University
Johns Hopkins University, Baltimore
University of Arizona
Stanford University
NHS Foundation Trust, London
Department of Veteran’s Affairs, Center for PTSD
Yale University
UNC, Chapel Hill Medical Center
University of Minnesota
University of Zurich, Switzerland
University College London
School of Science, University of Buenos Aires, Argentina
Royal London Hospital
New York University, Bellevue Hospital
And dozens more all confirm this medicine’s potential and effectiveness.
All of them are coming to the same conclusion…
This radical new treatment could be a godsend for millions of chronically ill people suffering from otherwise incurable diseases.
After decades of one failure after another, this Molecule 520 is the breakthrough doctors have dreamed of…
It has the power to treat 10–15 different intractable diseases…
Chasing the illness or addiction from a person’s body, almost like a “medical exorcism.”
Often in a single dose.
What Is This Molecule 520?
Perhaps the most amazing thing about this Molecule 520 is how simple it is.
Most “medicine” these days is a complex compound of heavy-duty and unpronounceable chemical ingredients.
This new medicine is made up of just one molecule.
But a molecule so powerful it is about to change conventional medicine as we know it.
It’s plant-based and naturally occurring in our environment.
So it has almost zero side effects, unlike most medications.
Here’s a picture of the molecule:
To the average person, this might look like any other molecule.
But to the trained eye, it’s very, very different.
And its difference and “magic” lie in how it treats disease.